Viewing Study NCT00436566

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-01-24 @ 10:01 PM
Study NCT ID: NCT00436566
Status: COMPLETED
Last Update Posted: 2022-08-05
First Post: 2007-02-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Cardiac Toxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cardiac toxicity View
None male breast cancer View
None stage I breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View